Manufacturing AbbVie opts for North Carolina to house $1.4bn manufacturing site Pharmaceutical TechnologyThis Durham-based facility will be AbbVie's first manufacturing site in the state, and will become a centre of excellence for SVP production.ManufacturingRead full story pharminent April 23, 2026 (Last updated: April 23, 2026) Pharmaceutical Technology This Durham-based facility will be AbbVie’s first manufacturing site in the state, and will become a centre of excellence for SVP production. ManufacturingRead full story Post navigation Previous: MSD teams up with Google Cloud on agentic AI transformationNext: Sanofi receives FDA approval for Tzield in paediatric diabetes Related Stories Manufacturing Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing pharminent May 7, 2026 Manufacturing Lilly inflates US facility investment spending by $4.5bn pharminent May 6, 2026 Manufacturing PCI adds US sterile fill/finish capabilities through $1B global expansion drive pharminent May 4, 2026
